DUB3 stabilizes GCase and attenuates pathological α-synuclein-induced neurodegeneration

Heterozygous GBA1 mutations are the most common genetic risk factor for development of Parkinson’s disease (PD). The loss of catalytic activity of GCase due to its quantitative protein reduction is linked the neurodegeneration, the mechanisms regulating GCase protein stability remain incompletely understood. Here, we screened 69 deubiquitinating enzyme constructs and identified DUB3 as a candidate regulator of GCase-associated ubiquitination and stability. DUB3 associated with both WT and L444P GCase, reduced GCase-associated ubiquitination, and increased GCase protein stability. WT DUB3, but not the catalytically inactive C89S mutant, increased endogenous GCase abundance in lysosome-enriched fractions. DUB3 deficiency reduced GCase protein levels and increased vulnerability to α-synuclein (α-Syn) preformed fibril (PFF)-induced toxicity in SH-SY5Y cells. Conversely, DUB3 overexpression increased GCase activity and reduced α-Syn PFF-induced pathological α-Syn accumulation and toxicity in primary WT and Gba1 L444P heterozygous knock-in mutant ( Gba1 +/L444P ) neurons. DUB3 expression did not reduce α-Syn or glucosylceramide accumulation in GBA1-knockout cells, supporting a contribution of GCase to these cellular effects. In vivo, concurrent administration of DUB3-expressing AAV5 and α-Syn PFF reduced pathological α-Syn accumulation, dopaminergic neuronal loss, and striatal fiber loss and improved motor performance in both WT and Gba1 +/L444P mice. Taken together, our results identify DUB3 as a previously unrecognized deubiquitinase that regulates GCase stability and its activity, thereby mitigating α-Syn PFF-induced pathology, dopaminergic neuron loss, and behavioral deficits in both WT and Gba1 +/L444P models. These findings establish the DUB3-GCase pathway as a potential therapeutic approach for PD with or without GBA1 mutations.

Authors

Institutions

Publication Details

Journal
Acta Neuropathologica Communications
Published
2026-11-19
DOI
https://doi.org/10.1186/s40478-026-02481-x
Primary Topic
Lysosomal Storage Disorders Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

DUB3 stabilizes GCase and attenuates pathological α-synuclein-induced neurodegeneration

Joonseo Lee, Sangjune Kim, Hyeonwoo Park, Haeun Park et al.
Acta Neuropathologica Communications
Lysosomal Storage Disorders Research
article

DUB3 stabilizes GCase and attenuates pathological α-synuclein-induced neurodegeneration

Joonseo Lee, Sangjune Kim, Hyeonwoo Park, Haeun Park, Sin Ho Kweon, Han Seok Ko, Hyo Je Cho, Jihoon Nah, Jae Hong Park, Jung-Hyun Choi, Sang‐Min Jang, Sung Joong Lee, Saebom Lee, Priya Thakur
article en

Abstract

Heterozygous GBA1 mutations are the most common genetic risk factor for development of Parkinson’s disease (PD). The loss of catalytic activity of GCase due to its quantitative protein reduction is linked the neurodegeneration, the mechanisms regulating GCase protein stability remain incompletely understood. Here, we screened 69 deubiquitinating enzyme constructs and identified DUB3 as a candidate regulator of GCase-associated ubiquitination and stability. DUB3 associated with both WT and L444P GCase, reduced GCase-associated ubiquitination, and increased GCase protein stability. WT DUB3, but not the catalytically inactive C89S mutant, increased endogenous GCase abundance in lysosome-enriched fractions. DUB3 deficiency reduced GCase protein levels and increased vulnerability to α-synuclein (α-Syn) preformed fibril (PFF)-induced toxicity in SH-SY5Y cells. Conversely, DUB3 overexpression increased GCase activity and reduced α-Syn PFF-induced pathological α-Syn accumulation and toxicity in primary WT and Gba1 L444P heterozygous knock-in mutant ( Gba1 +/L444P ) neurons. DUB3 expression did not reduce α-Syn or glucosylceramide accumulation in GBA1-knockout cells, supporting a contribution of GCase to these cellular effects. In vivo, concurrent administration of DUB3-expressing AAV5 and α-Syn PFF reduced pathological α-Syn accumulation, dopaminergic neuronal loss, and striatal fiber loss and improved motor performance in both WT and Gba1 +/L444P mice. Taken together, our results identify DUB3 as a previously unrecognized deubiquitinase that regulates GCase stability and its activity, thereby mitigating α-Syn PFF-induced pathology, dopaminergic neuron loss, and behavioral deficits in both WT and Gba1 +/L444P models. These findings establish the DUB3-GCase pathway as a potential therapeutic approach for PD with or without GBA1 mutations.

Acta Neuropathologica Communications
Johns Hopkins University (US), Chungbuk National University (KR), Johns Hopkins Medicine (US), University of California San Diego (US)
Lysosomal Storage Disorders Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon